Vouchers to Promote Tdap Vaccination
NCT01860378 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 149
Last updated 2015-04-03
Summary
This study is a small-scale randomized, placebo-controlled factorial trial of two interventions to increase Tetanus, diphtheria and acellular pertussis (Tdap) immunization rates among infant caregivers. Specifically, the trial will compare a full cost vs. $5 Tdap voucher with or without an educational video.
Conditions
Interventions
- OTHER
-
Full price
Participants will receive a voucher for the full price of a Tdap vaccine ($63.99) + a baby care product voucher or gift card
- OTHER
-
$5 off
Participants will receive a voucher for $5 off a Tdap vaccine + a baby care product voucher or gift card.
Sponsors & Collaborators
-
Robert Wood Johnson Foundation
collaborator OTHER - collaborator OTHER
-
Children's Hospital of Philadelphia
lead OTHER
Principal Investigators
-
Kristen A Feemster, M.D. · Children's Hospital of Philadelphia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2014-03-31
- Completion
- 2015-03-31
Countries
- United States
Study Locations
More Related Trials
-
Pertussis Vaccine in Healthy Pregnant Women
NCT00707148 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of Tetanus, Diphtheria and Mono Component Acellular Pertussis (TdaP) Vaccine in Comparison to Tetanus and Diphtheria (Td) Vaccine When Given as Booster Vaccinations to Adults
NCT01033877 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older
NCT00457249 ·Status: COMPLETED ·Phase: PHASE4
-
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
NCT06184542 ·Status: RECRUITING ·Phase: PHASE1
-
A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine
NCT00109330 ·Status: COMPLETED ·Phase: PHASE3
-
Pertussis Maternal Immunization Study
NCT00553228 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
NCT00004799 ·Status: COMPLETED ·Phase: PHASE3
-
Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
NCT01346293 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
NCT01529645 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants
NCT02477995 ·Status: COMPLETED ·Phase: PHASE3
-
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
NCT00304265 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of BCG on TDaP-IPV Vaccination
NCT02771782 ·Status: UNKNOWN ·Phase: PHASE4
-
Tdap Vaccine in Post-Partum Women
NCT01711645 ·Status: COMPLETED ·Phase: PHASE4
-
Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)
NCT02382913 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers
NCT07213089 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
4 Pillars Toolkit for Adolescent Vaccination
NCT02165722 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
NCT05091619 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
NCT00870350 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™
NCT00802867 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
NCT05951725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Tdap and Biomarkers of Alzheimer's Disease
NCT05183516 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
TDAP Safety in Pregnant Women
NCT02209623 ·Status: COMPLETED
-
Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children
NCT05870618 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of Adacel Vaccination in Pregnancy at Preventing Pertussis in Infants < 2 Months of Age in the United States
NCT05040802 ·Status: COMPLETED
-
Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9
NCT00489970 ·Status: COMPLETED ·Phase: PHASE3